In most eukaryotes, histone methylation patterns regulate chromatin architecture and function: methylation of histone H3 lysine-9 (H3K9) demarcates heterochromatin, whereas H3K4 methylation demarcates euchromatin. We show here that the S. pombe JmjC-domain protein Lid2 is a trimethyl H3K4 demethylase responsible for H3K4 hypomethylation in heterochromatin. Lid2 interacts with the histone lysine-9 methyltransferase, Clr4, through the Dos1/ Clr8-Rik1 complex, which also functions in the RNA interference pathway. Disruption of the JmjC domain alone results in severe heterochromatin defects and depletion of siRNA, whereas overexpressing Lid2 enhances heterochromatin silencing. The physical and functional link between H3K4 demethylation and H3K9 methylation suggests that the two reactions act in a coordinated manner. Surprisingly, crossregulation of H3K4 and H3K9 methylation in euchromatin also requires Lid2. We suggest that Lid2 enzymatic activity in euchromatin is regulated through a dynamic interplay with other histone-modification enzymes. Our findings provide mechanistic insight into the coordination of H3K4 and H3K9 methylation.
INTRODUCTION
In eukaryotic cells, chromatin is organized into euchromatic and heterochromatic subdomains. Euchromatin is gene rich and transcriptionally active, whereas heterochromatin is highly condensed during mitotic interphase and, until recently, was thought to be transcriptionally inert. Heterochromatin plays a pivotal role in genome stability, chromosome segregation, and gene regulation (Lippman and Martienssen, 2004 ). Histones, the major chromatin-packaging proteins, are subject to posttranslational modifications such as acetylation and methylation, which have emerged as critical components for regulating chromatin. Methylation commonly occurs at lysine residues at the histone N-terminal tails, such as H3-lys4 (H3K4) and H3-lys9 (H3K9). The methylation pattern orchestrated for different residues defines the functional status of the surrounding chromatin. For example, H3K4 and H3K9 methylation levels are mutually exclusive, a chromatin phenomenon conserved from fission yeast to human. Whereas H3K9 hypermethylation and H3K4 hypomethylation are the hallmarks of heterochromatin, H3K4 hypermethylation and H3K9 hypomethylation are usually associated with euchromatin (Fischle et al., 2003; Lachner et al., 2004) .
Histone lysine residues can be mono-, di-, or trimethylated (Lachner et al., 2004) . These modifications are regulated by two classes of enzymes with opposing activities: histone methyltransferases, which, in general, are SET-domain proteins, and the newly discovered histone demethylases Shi and Whetstine, 2007) . The first lysine histone demethylase identified was Lsd1, a nuclear amine oxidase (Shi et al., 2004) . Subsequently, a second family of histone demethylases, members of which contain the signature JmjC domain, was found. Members of this evolutionarily conserved family catalyze the lysine demethylation of histones through an oxidative reaction that requires iron Fe(II) and a-ketoglutarate (a-KG) as cofactors . The discovery of histone demethylases raises a fundamental question: how are the activities of these enzymes coordinated with the histone methyltransferases to ensure the establishment of a proper methylation pattern, such as mutually exclusive methylation at H3K4 and H3K9?
To address this question, we used the fission yeast Schizosaccharomyces pombe, an important model organism for understanding chromatin regulation. As in most other eukaryotes, fission yeast euchromatin is primarily marked by H3K4 methylation catalyzed by a conserved histone methyltransferase, Set1 (Noma and Grewal, 2002) . Interestingly, the Set1 complex is physically associated with a JmjC-domain protein, Little imaginal discs 2 (Lid2) (Roguev et al., 2003) , whose function is the study of this report. S. pombe euchromatin is also regulated by the conserved histone demethylase Lsd1. Lsd1 exhibits H3K9 demethylase activity, and it both coactivates the transcription of euchromatin genes and defines the heterochromatin boundary by antagonizing H3K9 methylation .
S. pombe heterochromatin is composed of centromeres, telomeres, and the mating-type region, all of which are rich in repetitive sequences (Lippman and Martienssen, 2004) . The heterochromatin-enriched H3K9 methylation is catalyzed by Clr4, a homolog of the mammalian histone methyltransferase SUV39H1 (Nakayama et al., 2001) . How H3K4 hypomethylation is achieved is elusive. H3K9 methylation creates the binding sites for Swi6, a HP1 homolog, to generate a stable, transcriptionally repressive structure. The catalytic activity of Clr4 is dependent upon its interactions with a WD-propeller-repeat protein, Rik1, which is the homolog of the human DNA damage-binding protein DDB1 (Nakayama et al., 2001 ). We and several other groups have previously identified two key heterochromatin factors, Dos1/Clr8 and Dos2/Clr7, which physically associate with Rik1 to promote Clr4-mediated H3K9 methylation, and another component, the ubiquitin ligase Cul4 (Li et al., 2005; Horn et al., 2005; Hong et al., 2005; Thon et al., 2005) .
The RNA interference (RNAi) machinery includes Argonaute (Ago1), Dicer (Dcr1), and the RNA-dependent RNA polymerase RdRP (Rdp1) and is required for H3K9 methylation in fission yeast heterochromatin (Volpe et al., 2002) . Ago1 is assembled into the RITS (RNA-induced initiation of transcriptional gene silencing) complex along with Tas3, the chromodomain protein Chp1, and small RNAs . The RITS complex recruits RDRC, which includes Rdp1, for small RNA amplification (Motamedi et al., 2004) . The association of RITS with chromatin depends on the binding of the chromodomain of Chp1 to methylated H3K9 domains (Partridge et al., 2002) . Deletion of Clr8, Clr7, or Clr4 results in the loss of small heterochromatic RNAs, which is likely due to disruption of RITS from heterochromatin (Li et al., 2005; Motamedi et al., 2004) . Conversely, H3K9 methylation by the Rik1 complex depends on the small RNA-guided endonuclease activity of Ago1 (Irvine et al., 2006) .
In this study, we identify and characterize an interacting partner of Clr8, the JmjC-domain protein Lid2. We demonstrate that Lid2 is an H3K4me3 demethylase, and we further reveal that it is a novel, to our knowledge, silencing factor that associates with the Clr8-Rik1 complex to mediate H3K9 methylation and small RNA production. We demonstrate a direct functional and physical interaction between H3K4 demethylation and H3K9 methylation, suggesting a novel mechanism responsible for coupling the two reactions in heterochromatin. Importantly, Lid2 also has an unexpected role in regulating the crosstalk between H3K4 and H3K9 methylation in euchromatin. Finally, we explore the roles of plant homeodomain (PHD) domains in these pathways. Lid2 is conserved, and these mechanisms have significant implications for understanding coordinated regulation of histone modifications in multicellular organisms.
RESULTS

The JmjC-Domain Protein Lid2 Interacts with Clr8
To identify proteins associated with Dos1/Clr8, we generated a yeast strain carrying an N-terminal TAP-tagged Clr8 at its endogenous location by replacing the kanamycin marker in the clr8D mutant. In clr8D, GFP-Swi6 showed a diffuse distribution instead of forming the 3-5 foci characteristic of its wild-type (WT) localization. The diffuse phenotype was fully rescued by TAP-Clr8, indicating that the TAP-tagged Clr8 is functional ( Figure 1A) . We isolated the Clr8 protein by immunoprecipitation with the TAP tag. Mass spectrometry analysis revealed that the purified fraction included Clr8 and Cul4, consistent with previous findings (Hong et al., 2005; Thon et al., 2005) , as well as a 170 kDa JmjC-domain protein, Lid2 ( Figure 1B ). We were surprised to find Lid2 in the silencing complex, since it has been reported that Lid2 interacts with the H3K4 methyltransferase Set1 (Roguev et al., 2003) . Lid2 is a homolog of the Drosophila Trithorax protein, Lid, and mammalian RBP2 and PLU-1 (Roguev et al., 2003; Yamane, et al., 2007) . Besides the JmjC domain, Lid2 contains three PHD domains and a JmjN domain ( Figure 1C ).
To confirm the interaction between Lid2 and Clr8, we created a C-terminal TAP-tagged Lid2 strain. The strain was indistinguishable from WT cells, suggesting that TAP does not interfere with Lid2 function. We also generated a fully functional Myctagged Clr8 and crossed it into the strain with the TAP-tagged Lid2. Coimmunoprecipitation (Co-IP) showed that Myc-Clr8 coprecipitated with Lid2 ( Figure 1D ). We also found that Lid2 coprecipitated with Myc-Rik1 ( Figure S1 , available online). These results confirmed that Lid2 is associated with the Clr8-Rik1 complex in vivo.
Lid2 Is an Essential Chromatin-Binding Protein Required for Chromosome Segregation To examine whether Lid2 directly associates with chromatin, we performed an in situ chromatin-binding assay. Cells containing GFP-Lid2 or Mcm4-GFP as a control were washed in 1% Triton X-100. Mcm4-GFP associates with chromatin only at anaphase/ G1 (Kearsey et al., 2000) . At other stages, the GFP signal is nearly undetectable after the detergent treatment ( Figure 2A ). In contrast, GFP-Lid2 is resistant to detergent extraction, indicating that Lid2 is a chromatin-binding protein (Figure 2A ). We then analyzed Lid2-TAP by Chromatin IP (ChIP) with primers that amplify the centromere or the mating-type region. The ChIP assay showed enrichment of DNA from centromeres and the matingtype region, indicating that Lid2 is associated with heterochromatin ( Figure 2B ).
We deleted one copy of lid2 + by kanamycin reporter gene re-
, and tetrad analysis was performed after sporulation. Only two germinating spores from a tetrad were viable, confirming that lid2 + is an essential gene. The JmjC domain is the signature catalytic motif of a family of histone demethylases. To further characterize Lid2 function, we deleted this domain. The resulting lid2-j mutant grew significantly slower than WT and frequently exhibited an aberrant elongated cell shape ( Figure 2C ). As visualized by DAPI staining, 28% of the cells contained fragmented nuclear DNA ( Figure 2D ), indicating that the mutant nucleus is disorganized. The abnormal nucleus of the mutant could result from chromosome missegregation during cell division. To test this possibility, we examined the growth rate of cells grown on the microtubule-destabilizing drug thiabendazole (TBZ). As shown in Figure S2 , lid2-j, like clr8D, is hypersensitive to TBZ, a defect commonly observed in heterochromatin mutants with defective centromeres (Li et al., 2005) .
Lid2 Is Required for Heterochromatin Silencing
The availability of the lid2-j mutant provided an opportunity to study Lid2's molecular function. First, we asked whether Lid2 is involved in heterochromatin assembly. S. pombe centromeres are organized into core regions (ctr), inner repeats (imr), and outer repeats (otr). The imr and otr regions are heterochromatic, and reporter genes inserted at these regions are transcriptionally silenced. To determine whether Lid2 contributes to peri-centromeric silencing, we crossed lid2-j into strains carrying the reporter gene ura4 + at the imr and otr regions. Silencing assays were performed by using either minimal media lacking uracil or media containing the counterselective drug 5-FOA, which is toxic to cells expressing the ura4 + gene product. We found that deletion of the Lid2 JmjC domain resulted in the complete loss of ura4 + silencing at both the otr and imr loci (Figures 3A and 7A) . Using a similar assay, we showed that silencing at the mating-type region was likewise reduced ( Figure 3A) .
A crucial step in heterochromatin assembly is the methylation of H3K9 by Clr4, which creates a binding site for Swi6, as well as for the chromodomain of Chp1. We investigated whether H3K9 methylation and Swi6 binding were affected in lid2-j. As shown in Figure 3B , H3K9 methylation at the centromere was completely abolished. In contrast, H3K4me3 methylation was increased significantly ( Figure 3C ), suggesting that Lid2 plays a role in the coordination of H3K4 and H3K9 methylation. Correspondingly, deletion of the JmjC domain results in drastic reduction of Swi6 binding ( Figure S3 ). We then determined whether Lid2 is required for the recruitment of Clr4 to heterochromatin. We carried out a ChIP experiment by using lid2-j or clr8D containing an N-terminal FLAG-tagged Clr4. The localization of Clr4 at centromeres is abrogated in both mutants ( Figure 3D ). Thus, Lid2 and Clr8 are both required for recruitment of Clr4 to heterochromatin.
Lid2 Displays Histone H3K4me3 Demethylase Activity
Since JmjC is the essential catalytic motif of a class of histone demethylases , we investigated whether Lid2 has histone demethlylase activity. It is unlikely that Lid2 is a H3K9 histone demethylase because overexpressing Lid2 enhances H3K9 methylation (Figures 5F and 5G). We thus examined whether Lid2 could demethylate H3K4. We overexpressed Lid2 in WT cells and carried out immunostaining by using antibodies against H3K4me2 and H3K4me3. In WT, both antibodies stained the nuclei strongly. The level of H3K4me2 in cells overexpressing Lid2 was the same as in WT. However, H3K4me3 staining was reduced to nearly undetectable levels in 82% of the cells overexpressing Lid2, suggesting that Lid2 can specifically demethylate H3K4me3 ( Figure 4B ). Consistent with this finding, western blots showed that overexpression of Lid2 resulted in specific reduction of H3K4me3, but not H3K4me2 ( Figure 4D ).
The JmjC domains in histone demethylases contain a-KG and iron-binding sites, which are important for their enzymatic activity. The conserved a-KG-binding sites of Lid2 are indicated in blue, and the iron-binding sites are indicated in red in Figure 4A . To determine whether the iron-binding site plays a role in Lid2 function, we made a single point mutant by changing the conserved iron-binding histidine at amino acid position 512 to alanine. Immunostaining demonstrated that the reduction of H3K4me3 was largely compromised when overexpressing the mutant construct, indicating that Lid2 needs the iron-binding site for its H3K4 demethylation activity ( Figures 4B and 4D ). Lid2 has an unconventional JmjC domain for catalyzing demethylation. To test whether Lid2 has intrinsic histone demethylase activity, recombinant Lid2 protein purified from insect cells and TAP-purified Lid2 complex from S. pombe were incubated with a variety of histone peptides. Mass spectrometry was not able to detect any reduction of methylation of the peptides in any of these reactions. We then purified fission yeast chromatin from a WT strain and incubated it with the Lid2 complex purified by TAP tagging. Consistent with the in vivo results, this in vitro demethylation reaction demonstrated that Lid2 specifically demethylates H3K4me3, as shown by western blot ( Figure 4E ). This suggests that Lid2 does not work well on histone peptides, likely because the peptides lack the intrinsic structure of nucleosomes that this enzyme might require for function. Although we cannot rule out the possibility that Lid2 enzymatic activity requires other interacting components, such as the JmjC protein Jmj3/Ecm5, which is a part of the Lid2 complex (Roguev et al., 2003) , our results from overexpressing the WT and point mutant Lid2 support the idea that Lid2 is a genuine histone demethylase.
The identification of Lid2 as an H3K4me3 demethylase explains why H3K4me3 methylation levels in heterochromatin are increased in lid2-j. Furthermore, it establishes a direct physical and functional link between H3K4 demethylation and H3K9 methylation, and it suggests that the crosstalk between these two processes in heterochromatin assembly is organized in a coordinated fashion through the Clr8-Rik1 complex.
Lid2 Acts in the RNAi Pathway
RNAi plays an important role in the establishment and maintenance of centromere silencing. In the WT, the ''forward'' strand at the centromere is transcriptionally repressed. However, the ''reverse'' strand is transcribed by Pol II and is processed by the slicing activity of Ago1, which resides in the RITS complex (Volpe et al., 2002; Irvine et al., 2006 ). The sliced transcripts are then used as a template by RDRC to synthesize double-stranded RNA, which is subsequently processed by Dcr1 (Motamedi et al., 2004) . As a result, the centromeric transcripts are hardly detectable in the WT, but transcripts derived from both strands accumulate in RNAi mutants. clr4 and clr8 mutants also accumulate transcripts from both strands and lose small RNA. This is because the loss of H3K9 methylation in these mutants prevents binding of the Chp1 chromodomain, which, in turn, dissociates the RITS complex from chromatin.
To determine whether the forward and reverse transcripts from the dg-dh repeats accumulate in lid2-j, we performed strand-specific RT-PCR by using total RNA purified from the mutant. As shown in Figure 5A , both forward and reverse centromeric strands were detected in lid2-j and accumulated at the same level as in clr8D, suggesting that Lid2 is involved in the RNAi pathway. Consistent with this, a genomic tiling microarray indicates that transcripts across the heterochromatic centromere region in lid2-j are significantly elevated ( Figure S4 ). We then examined whether the generation of small centromeric RNA is affected in lid2-j by northern blot analysis. As shown in Figure 5B , siRNA is barely detectable.
Next, we asked whether the loss of small RNA is due to the dissociation of RITS from heterochromatin. To answer this question, we performed a ChIP assay by using an antibody raised against Ago1. As shown in Figure 5C , the association of Ago1 with the centromere is significantly reduced in lid2-j, indicating that Lid2 is required for RITS to load onto centromeres.
Lid2 Functions Cooperatively with Clr8 to Promote Heterochromatin Formation
To dissect the functional relationship between Lid2 and Clr8, we determined whether the association of Clr8 with heterochromatin depends on Lid2 or vice versa. In WT cells, Myc-Clr8 associates with centromere otr regions, but not in lid2-j, suggesting that Lid2 is required for Clr8 association with heterochromatin ( Figure 5D ). We next determined whether Lid2 association with the centromere is dependent on Clr8 by using the clr8D and WT strains carrying Lid2-TAP. As shown in Figure 5D , whereas Lid2 accumulated at centromeres in the WT, the centromere localization of Lid2 in the clr8 mutant is significantly decreased. These data indicate that Clr8 and Lid2 mutually affect each other's recruitment to heterochromatic centromere regions.
To further investigate the relationship between Lid2 and Clr8, we constructed a full-length lid2 + in the pREP2 vector and expressed it in lid2-j and clr8D mutants containing a reporter, ade6 + , at the centromere otr region. In WT cells, this ade6 + is strongly silenced, leading to red-colored colonies on adeninelimited media. In heterochromatin mutants, such as clr8D, the 
ade6
+ is fully expressed, resulting in white colonies. We found that pREP2-lid2 + completely restored silencing in the lid2 mutant ( Figure 5E ), which confirms that Lid2 indeed is responsible for the mutant phenotype. However, expressing Lid2 in the clr8D mutant had no significant effect, and clr8 + also failed to rescue lid2-j ( Figure 5E ), suggesting that Lid2 and Clr8 function cooperatively to modulate heterochromatin assembly.
Lid2 Regulates Heterochromatin Silencing in a Dose-Dependent Manner
To determine the effect of the histone demethylase activity of Lid2 on heterochromatin function, we performed the same silencing assays with a strain containing the point mutation at the conserved iron-binding histidine, lid2 H512A . As indicated by colony color in Figure 5E , the point mutation resulted in a significant loss of silencing at the centromere otr region. Correspondingly, H3K9me2 methylation at the region was abolished, whereas H3K4me3 methylation was increased more than seven-fold ( Figure S5 ). In addition, a Co-IP with the TAP-tagged version of lid2 H512A showed that the point mutation had little effect on the interaction of Lid2 with its interacting partners, such as Cul4 and Set1 ( Figures S6 and S11 ). These results suggest that the histone demethylase activity of Lid2 is directly involved in heterochromatin silencing.
To further dissect the effect of Lid2 on centromeric silencing, we overexpressed Lid2 under the control of the nmt promoter in lid2-j carrying ade6 + at the otr region, and we plated it onto the thiamine-free minimal EMM media lacking adenine. As expected, lid2-j grew more robustly than WT cells because the ade6 + at the mutant otr region is derepressed. In contrast to WT, cells overexpressing Lid2 grew poorly even after a 10-day incubation, indicating that silencing at the centromere is enhanced by overexpressing Lid2 ( Figure 5F ). Consistent with this result, H3K9 methylation was increased at heterochromatic regions ( Figure 5G ). These data suggest that H3K9 methylation at heterochromatin is positively regulated by Lid2 in a dose-dependent manner, and thus demethylation of H3K4me3 by Lid2 may be a rate-limiting factor for heterochromatin assembly, determining the degree of H3K9 methylation.
Ectopic Heterochromatin Is Formed in the lid2-j Mutant, but Not in the Point Mutant lid2
H512A
We next examined Swi6 localization in the lid2-j mutant by using GFP-Swi6. In WT vegetative cells, 3-4 GFP-Swi6 spots are observed. This is because the three centromeres cluster on the nuclear envelope in the vicinity of the spindle pole body, whereas telomeres loosely cluster on the nuclear envelope, apart from centromeres. clr4 and clr8 mutants have a diffuse Swi6 localization due to the disruption of heterochromatin. To our surprise, we did not see the same GFP-Swi6 pattern in the lid2-j mutant as in clr8D. Rather, we found that 78% of the cells contain more than five GFP-Swi6 spots, with nearly 30% having more than ten spots ( Figure 6A ). The abnormal distribution of Swi6 can also be observed in meiotic horsetail-stage nuclei ( Figure 6A ). The aberrant Swi6 localization is not caused by defects in centromere or telomere clustering since the distribution of centromeres and telomeres, as marked by Cnp1-GFP or Taz1-GFP, respectively, is unaffected in the lid2-j mutant ( Figure S7 ). We further confirmed that telomeres cluster normally by visualizing their distribution in a lid2-j strain carrying mCherry-Swi6 and the telomere marker Taz1-GFP ( Figure S7 ). These results suggest that heterochromatin is induced in euchromatic regions in lid2-j.
To further examine whether ectopic heterochromatin is generated in lid2-j, we took advantage of the strain L(HpaI)::ura4 + , which carries a copy of ura4 + inserted in the euchromatin immediately adjacent to the heterochromatic mating-type region ( Figure 6B ). ura4 + is expressed in the WT strain; however, in lid2-j mutant cells, ura4 + expression is strongly repressed, as assayed by growth on EMM without uracil and on FOA ( Figure 6B ). ChIP assays also indicate that H3K4 methylation in the region was significantly reduced compared to the WT, whereas H3K9 methylation was increased ( Figure S8 ). Furthermore, Swi6 can be readily detected in this region ( Figure S8 ). Thus, Lid2 helps to establish the heterochromatin/euchromatin boundary near the mating-type locus. This phenotype is similar to mutants in the histone demethylase Lsd1, which regulates euchromatin integrity by antagonizing H3K9 methylation . This prompted us to examine the genome-wide transcription profile in the lid2-j mutant. A genomic tiling microarray was hybridized with total RNA extracted from lid2-j. Approximately 50% (2665 out of 5241) of the genes in the genome were downregulated in mutant cells compared to WT ( Figure 6C ; Table S3 ), consistent with the formation of ectopic heterochromatin. We further noted the striking similarity of the genome-wide transcription profiles of the lid2-j and lsd1D mutants ( Figure 6C ), suggesting that the two histone-modification enzymes may function together in euchromatic regions. We then analyzed H3K4 and H3K9 methylation at the promoter region of one of the Lsd1 target genes, SPCC1620.06c + . We observed enhanced H3K9 and diminished H3K4 methylation at the promoter in the lid2-j mutant ( Figure S9 ), similar to the heterochromatin/euchromatin boundary at the mating-type locus. Together, these results show that ectopic heterochromatin is generated in lid2-j mutant cells, suggesting that, in addition to its essential role in heterochromatin assembly, Lid2 is also required for euchromatin function, similar to the requirement for Lsd1.
To examine whether catalytic activity was required for this euchromatic function, we performed the silencing assay by using the point mutant lid2
H512A carrying L(HpaI)::ura4 + . Unlike lid2-j, the lid2 H512A strain grew well on EMM without uracil ( Figure 6B ), indicating that the heterochromatin/euchromatin boundary near the mating-type locus was not perturbed. We also examined the expression of six Lsd1 target genes in the lid2 H512A mutant by RT-PCR, and we found that, unlike the lid2-j mutant, there was little difference in expression relative to WT cells ( Figure S10 ; data not shown). These results demonstrate that euchromatin in lid2 H512A appears intact, and further demonstrate that the euchromatic defects in lid2-j might be the result of interaction with additional proteins, rather than loss of Lid2 catalytic activity.
Lid2 Regulates H3K4 and H3K9 Methylation in Euchromatin by Acting Cooperatively with Set1 and Lsd1
Lsd1 is associated with the promoter of SPCC1620.06c + ), but we found that this association was disrupted in lid2-j cells ( Figure 6D ). We therefore examined whether Lid2 physically interacts with Lsd1. Lid2-TAP and Lsd1-Myc coprecipitated ( Figure 6E ), suggesting recruitment of Lsd1 to chromatin via interactions with Lid2. Lid2 also interacts with the H3K4 methyltransferase Set1 (Roguev et al., 2003 ), but we found that Lid2-j interacts poorly with C-terminal Myc-tagged Set1, indicating that the JmjC domain is required for interaction ( Figure 6G) . Consistently, the level of Set1 was reduced at the promoter of SPCC1620.06c + in lid2-j ( Figure 6F ). In contrast to the overexpression of Lid2 alone, which leads to a dramatic decrease in H3K4me3 ( Figure 4B ), reduction of H3K4me3 is minimal when Set1 or Lsd1 is also overexpressed ( Figure 4C ). These results suggest that Lid2's histone demethylase activity is suppressed or counteracted in euchromatin by Set1 and Lsd1. Collectively, our data suggest that Lid2 is required for the recruitment of Set1 and Lsd1 to euchromatin, which results in H3K4 methylation and a concerted H3K9 demethylation. Additionally, they suggest that Lid2 histone demethylase activity is regulated through interactions with Set1 and Lsd1.
The Role of PHD Fingers
To investigate the role of PHD domains in Lid2, we systematically deleted the three domains to create mutant strains lid2-phd1, lid2-phd2, and lid2-phd3 ( Figure 7A ). Although not essential for viability, silencing at the imr region in lid2-phd2 and lid2-phd3 mutants was significantly impaired, whereas lid2-phd1 showed only a slight defect ( Figure 7A ). Obvious reduction of H3K9 methylation was also observed in lid2-phd2 and lid2-phd3 mutants ( Figure S12 ). We also examined the GFP-Swi6 distribution in the mutants ( Figure 7B ). Whereas the lid2-phd1 mutant is similar to the WT, the nuclei in the lid2-phd2 and lid2-phd3 mutants often contained excessive GFP-Swi6 dots, suggesting that euchromatin assembly is disrupted in the mutants. PHD domains bind to methylated lysines (Taverna et al., 2007) ; thus, TAPtagged fusion proteins were purified and incubated with biotinylated histone peptides methylated at various lysine residues. A peptide pull-down assay showed that the PHD2 domain preferentially binds to H3K9me3 peptide ( Figure 7C ). However, PHD1 and PHD3 domains did not associate with any modified histone peptides, suggesting that binding may require other Lid2 domains, an intact nucleosome, or even other proteins.
DISCUSSION
To our knowledge, this is the first report of a direct physical and functional link between H3K4 demethylation and H3K9 methylation, which suggests a novel mechanism for the crossregulation of the two reactions ( Figure 7D ). Furthermore, we provide evidence for the role of Lid2 in the cross-regulation of H3K4 and H3K9 methylation in euchromatin by demonstrating that it recruits the H3K4 methyltransferase Set1 and the H3K9 demethylase Lsd1 in a mechanism that does not depend on Lid2's catalytic activity ( Figure 7D ). One possibility is that Lid2 promotes euchromatic histone modification by guiding Set1 and Lsd1 to methylated H3K9 residues via its PHD domain, which interacts with H3K9me3. Thus, the duality of Lid2 function between euchromatin and heterochromatin implicates a role in balancing the assembly and function of these two domains.
Lid2 is a highly conserved protein, and its homologs can be found in many multicellular eukaryotes, from Drosophila Lid to mammalian RBP2 and PLU-1. Recently, Lid, RBP2, and PLU-1 have all been characterized as H3K4 histone demethylases (Eissenberg et al., 2007; Iwase et al., 2007; Yamane et al., 2007) . However, their biological functions, especially in the context of chromatin regulation, are not well understood. We demonstrate here that Lid2, also a trimethyl (B) PHD2 and PHD3 domains affect GFP-Swi6 distribution. Aberrant GFP-Swi6 patterns were observed in lid2-phd2 and lid2-phd3, similar to lid2-j, suggesting that these PHD domains may also be involved in euchromatin assembly.
(C) The PHD2 domain preferentially binds to H3K9me3, indicated by the peptide pull-down assay.
(D) Model for Lid2 function: Lid2 demethylates heterochromatic H3K4me3 and also mediates H3K9 methylation by Clr4 through interaction with Clr8-Rik1 complex (upper panel). This stabilizes the RITS association with chromatin, which, in turn, recruits the RDRC complex to synthesize the double-stranded RNA for Dicer. At euchromatin (lower panel), Lid2 recruits Set1 and Lsd1 to maintain H3K4 methylation and, at the same time, removes H3K9 marks in actively transcribing genes. During the attenuation phase of transcription, Lid2 H3K4 demethylase activity could be triggered to reduce the H3K4 methylation level.
H3K4 demethylase, is a novel, to our knowledge, silencing factor, acting together with the Clr8-Rik1 complex to promote H3K9 methylation by Clr4. These results suggest that H3K4 demethylation by Lid2 and H3K9 methylation by Clr4 act in coordinated manner ( Figure 7D ). The concerted activity of these two reactions explains how H3K9 hypermethylation and H3K4 hypomethylation are maintained at heterochromatin. Lid2 is the first example, to our knowledge, of a histone demethylase directly involved in the RNAi pathway. The lid2-j mutant lost small RNA, similar to clr8D and clr4D, presumably because the loss of H3K9 methylation disrupts the association of RITS with chromatin through the chromodomain of Chp1. This disruption can result in a failure to recruit RDRC, preventing the further amplification of RNAi signals. In our model ( Figure 7D ), H3K4 demethylation by Lid2 takes place at an early stage of heterochromatin assembly, consistent with the observation that the lid2 mutant also disrupts the silencing of the mating-type region.
What is the role of Clr8? Several recent reports demonstrate that the human DDB1-CUL4 ligase complex interacts with multiple WD-repeat proteins, and they suggest that these interactions are important for modulating histone methylation (Lee and Zhou, 2007) . It was proposed that the WD proteins may function as substrate-specific adaptors for the DDB1-CUL4 complex. Clr8, a WD-repeat protein, may play a similar adaptor role. Unlike Lid2, overexpression of Clr8 does not affect heterochromatin silencing (data not shown); however, deletion of Clr8 causes complete loss of heterochromatin, suggesting that Clr8 functions as a structural component, i.e., adaptor, rather than as an enzyme. Thus, Clr8, together with Rik1, may provide an interaction interface between Lid2 and Clr4 to coordinate H3K4 demethylation and H3K9 methylation.
Other mutants in the Rik1 complex reported so far have growth defects, but none of them are essential . The fact that Lid2 is required for cell viability and that deletion of the JmjC domain has more severe growth abnormalities than clr8D and clr4D imply that Lid2 has additional functions. Consistent with this idea, we found that Lid2 associates with euchromatic regions, acting together with the H3K4 methyltransferase Set1 and the H3K9 demethylase Lsd1. Thus, in euchromatin, Lid2 may function as a structural link, directly or indirectly, between Set1 and Lsd1 to ensure the H3K4 hypermethylation and H3K9 hypomethylation of active genes ( Figure 7D ). Meanwhile, its own H3K4 demethylase activity is likely suppressed either by directly interacting with these partners, or it is perhaps counteracted by them. Deletion of lid2's JmjC domain may abrogate the association of Set1 and Lsd1 with chromatin, thereby resulting in aberrant H3K9 methylation and ectopic localization of Swi6. These euchromatin defects ( Figure 6C ), rather than the loss of Lid2 enzymatic activity, are the major reason for the severe growth phenotype of lid2-j, which is similar to the phenotype of lsd1. Consistent with the role of Lid2 at euchromatin, the equivalent lid mutants in Drosophila have phenotypes similar to the trithorax group of homeotic gene activators (Eissenberg et al., 2007; . Additionally, Lsd1 has a role in transcriptional corepression that is at least as important as coactivation , and could be explained in part by its association with Lid2.
The level of gene expression in euchromatin varies during the cell cycle as well as in response to environmental stimuli. When transcription is attenuated, we speculate that the H3K4 histone demethylase activity of Lid2 could be activated, presumably by dissociation of Lid2 from its interacting partners, to reduce the level of H3K4 methylation ( Figure 7D ). Perhaps chromatin factors in different subdomains, such as Clr8 and Lsd1, compete for interaction with Lid2 by binding to the JmjC domain to achieve a balance in the status of histone modifications between the two subdomains. Another S. pombe JmjC-domain protein, Jmj2, demethylates H3K4me2 and H3K4me3. Deletion of Jmj2 did not affect the H3K4me3 levels at centromeres and telomeres, although the mutant had mating-type silencing defects and an elevation of H3K4me3 in that region . One possibility is that Lid2 demethylates H3K4me3 to H3K4me2, which is further demethylated by Jmj2. Recently, the deoxyribonucleotide biosynthesis pathway has been implicated in regulating the heterochromatin boundary at the mating-type region in S. pombe (Singh and Klar, 2008) . However, its mechanism of action, especially its relationship with Lid2, is not clear.
The PHD domain recognizes histone lysine methylation (Taverna et al., 2007) . Unlike many other JmjC proteins, Lid2 and its homologs contain multiple, usually three, PHD domains. It is possible that the PHD domains in Lid2, either combinatorially or independently, recognize H3K9me3. This would allow for the recruitment of its own JmjC catalytic motif or other interacting histone-modifying enzymes to maintain epigenetic integrity. Furthermore, the Lid2 complex contains a PHD-domain protein, Snt2, and the JmjC-domain protein Jmj3 (Roguev et al., 2003) , which may provide another layer of control. So far, we have not found that Jmj3 has any histone demethylase activity. It is possible that the role of Jmj3 is to facilitate Lid2's enzymatic function through their interaction.
The human Lid2 homolog, RBP2, is also a transcriptional coactivator or corepressor in a context-dependent manner (Benevolenskaya et al., 2005) , suggesting that the duality of Lid2 function is likely conserved from S. pombe to mammals. Furthermore, RBP2 and PLU-1 have been linked to tumorgenesis: RBP2 is progressively downregulated in advanced and metastatic melanomas (Roesch et al., 2005) , whereas PLU-1 is overexpressed in breast cancer ; however, their underlying role in pathogenesis is still unclear. Our studies on Lid2 not only expand our view of chromatin regulation, but they also shed light on similar mechanisms in multicellular organisms and in human disease.
EXPERIMENTAL PROCEDURES
Fission Yeast Strains and Genetic Procedures S. pombe strains used in this study are listed in Table S1 . Standard genetic protocols for fission yeast were used (Moreno et al., 1991) .
Protein Purification and Mass Spectrometry
For TAP-tag purification, lysates were cleared by centrifugation and incubated with IgG Sepharose 6 Fastflow beads (Amersham Bioscience) for 2 hr. After washing, protein was eluted from the beads and incubated overnight with TEV protease (Invitrogen). The TEV eluate was added to S protein agarose (Novagen) for 3 hr. For Clr8, the eluted fractions from S protein agarose were analyzed by silver staining and were subjected to mass spectrometry at Cold Spring Harbor Laboratory (New York, NY). For the in vitro demethylase assay, the eluate from IgG Sepharose was concentrated in a Cen50 concentrator and further purified by a Superdex 200 gel-filtration column. Flag-Lid2 was purifed from Sf9 cells as described . Briefly, cell lysates from Sf9 cells were incubated with anti-FLAG beads for 4 hr. After washing, the proteins were eluted and subjected to dialysis.
Immunoprecipitation Assays
Whole-cell extracts were obtained by bead lysis in HB buffer (25 mM MOPS [pH 7.2], 15 mM EGTA, 15 mM MgCl 2 , 50 mM NaCl, 60 mM b-glycerophosphate, 1 mM DTT, 0.1 mM NaVO 3 , 0.0125 g/l proteolysis inhibitor [Sigma]) (Moreno et al., 1991) . Lysates were cleared by centrifugation and incubated with protein A Sepharose beads with antibody or IgG Sepharose 6 Fastflow beads (Amersham Bioscience) for 2 hr at 4 C. After washing, eluted proteins and input extracts were analyzed by western blotting. The antibodies used are listed in Supplemental Data.
In Situ Chromatin-Binding Assay
We used an in situ chromatin binding assay as described previously (Kearsey et al., 2000) . Briefly, the exponentially growing cells carrying GFP-Lid2 or Mcm4-GFP were collected and washed with 1% Triton X-100. After fixation in 3.7% formaldehyde and 10% methanol, cells were examined by epi-fluorescence microscopy.
ChIP Analysis
ChIP assays were carried out as previously described (Partridge et al., 2002) . In brief, chromatin prepared from cells fixed by 3% formaldehyde was immunoprecipitated by antibodies. Recovered DNA was analyzed by multiplex PCR. PCR products were separated on a 1.7% agarose gel and poststained with ethidium bromide. The antibodies and primers used are listed in Supplemental Data.
RT-PCR
Total RNA was extracted from cells growing at log phase by the RNeasy kit (QIAGEN). RT-PCR was performed by using a one-step RT-PCR kit (QIAGEN) with minor modifications from manufacturer recommendations, as previously described (Volpe et al., 2002) . Basically, in a first-strand cDNA synthesis reaction, RNA samples were incubated with primers complimentary to either forward or reverse centromeric transcripts. After heat inactivation of the reverse transcriptase, a second primer was added for the subsequent cycles of PCR amplification. Primers used for RT-PCR are listed in Supplemental Data.
Small RNA Northern Blot Small RNA was isolated from exponentially growing cells by using a mirVana miRNA isolation kit (Ambion). Northern blot was performed as described previously (Li et al., 2005) . Briefly, 25 mg small total RNA was resolved by a 15% denaturing acrylamide gel and transferred to a charged nylon membrane (Hybond-N+, Amersham). RNA blots were crosslinked and hybridized with probes specific for snoRNA69, or the centromere otr region.
In Vitro Histone Demethylation Assay
The histone demethylation assay was performed as described . Briefly, 2-10 mg insect cell-purified Lid2 protein or TAP-purified Lid2 complex from S. pombe was incubated with modified histone peptide substrates, including mono-, di-, and trimethylation at H3-K4, H3-K9, H3-K36, or H4-K20, or purified S. pombe chromatin in a histone demethylase buffer for 3 hr at 30 C. The reaction mixtures were analyzed by either MALDI-TOF mass spectrometry or western blot with antibodies against H3K4me2 or H3K4me3.
Microarray Analysis
Total RNA was extracted from cells growing at log phase by TRIzol (Invitrogen) and was further purified by RNeasy kit (QIAGEN). Two replicates were performed, each consisting of a single dye reversal, on a genomic tiling microarray whose probes are an average of 55 nt long, separated by 11 bases, and are spotted in duplicate in position-randomized locations on the array. After initial correlation plots were performed to ensure that replicate arrays were generally comparable, each array was normalized internally by using a position-independent loess. Arrays were then normalized against one another by using quantile normalization. Results were fit to a linear model in the Bioconductor package ''limma.'' Moderated t-statistics and log-odds of differential expression were computed by empirical Bayes shrinkage of the standard errors. Multiple testing error was addressed by controlling the false discovery rate to 0.05 via Benjamini and Hochberg's method .
Peptide Pull-Down Assay We carried out the peptide pull-down assays as described previously (Wysocka, 2006) . Briefly, Tap-purified PHD domains were precleared with avidin beads and incubated with avidin beads prebound with peptides. Approximately 10 mg peptide was used per pull-down. After washing, bound proteins were eluted from the resin and analyzed by western blot with anti-S-tag antibody. Peptides used are listed in Supplemental Data.
Immunostaining and Microscopy
Early log-phase cells were collected and fixed by formaldehyde. Immunostainings were performed by following standard procedures (Moreno et al., 1991) . Samples were analyzed by a fluorescence microscope (Olympus BX51) or a Delta Vision System (Applied Precision, Issaquah, WA). For Delta Vision acquisition, stacks of z-axis sections were subjected to reiterative deconvolution, and final projections were processed with SoftWoRX2.50 (Applied Precision).
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